Last reviewed · How we verify
NCT04198194
Apple Heart & Movement Study
trial testing Predictors of events in Prevention in 500,000 participants. Participants enrolled and being followed up; not accepting new ones.
28 February 2025
Quick facts
| Lead sponsor | Apple Inc. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 500,000 |
| Start date | 14 November 2019 |
| Primary completion | 28 February 2025 |
| Estimated completion | 28 February 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Predictors of events
Conditions studied
- Prevention — all drugs for Prevention →
Sponsor
Apple Inc. — full company profile →
Who can join
18 and older, any sex, with Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function. Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs. This can lead to new interventions and products that will help millions lead longer, healthier, and more active lives.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Pulse oximetry values from 33,080 participants in the Apple Heart & Movement Study.
Shapiro I, Stein J, MacRae C, O'Reilly M. · · 2023 · cited 11× · PMID 37500721 · DOI 10.1038/s41746-023-00851-6 -
Modeling personalized heart rate response to exercise and environmental factors with wearables data.
Nazaret A, Tonekaboni S, Darnell G, Ren SY, et al · · 2023 · cited 10× · PMID 37968567 · DOI 10.1038/s41746-023-00926-4 -
Understanding activity and physiology at scale: The Apple Heart & Movement Study.
Truslow J, Spillane A, Lin H, Cyr K, et al · · 2024 · cited 9× · PMID 39256546 · DOI 10.1038/s41746-024-01187-5 -
A wearable-based aging clock associates with disease and behavior.
Miller AC, Futoma J, Abbaspourazad S, Heinze-Deml C, et al · · 2025 · cited 1× · PMID 41115881 · DOI 10.1038/s41467-025-64275-4 -
Naturalistic sleep tracking in a longitudinal cohort: Uncertainty and bias in short duration sampling.
Goparaju B, de Palma G, Bianchi MT. · · 2025 · PMID 41183052 · DOI 10.1371/journal.pone.0334950 -
Deep sleep homeostatic response to naturalistic sleep loss.
Goparaju B, Ravindran S, Bianchi MT. · · 2025 · PMID 41052109 · DOI 10.1371/journal.pdig.0001021
Verify or expand the search:
- PubMed search for NCT04198194
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prevention
Currently open trials in the same condition.
- NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
- NCT07248280 — Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatie · Phase 3 · recruiting
- NCT07382583 — Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P · recruiting
- NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
- NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting
Other Apple Inc. trials
Trials by the same sponsor.
- NCT05872035 — Smartphone Enabled Hearing Study · NA · completed
- NCT05852951 — Cycle and Ovulation Study Expansion · completed
- NCT04912180 — Apple Respiratory Study · terminated
- NCT04699812 — Atrial Fibrillation Algorithms Clinical Validation Study · NA · completed
- NCT04247581 — ECG App Algorithms Clinical Validation Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04198194 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Apple Inc.
- Last refreshed: 21 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04198194.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing